KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Finished Goods (2016 - 2018)

Biogen has reported Finished Goods over the past 9 years, most recently at $133.5 million for Q4 2018.

  • For Q4 2018, Finished Goods fell 15.18% year-over-year to $133.5 million; the TTM value through Dec 2018 reached $133.5 million, down 15.18%, while the annual FY2018 figure was $133.5 million, 15.18% down from the prior year.
  • Finished Goods for Q4 2018 was $133.5 million at Biogen, down from $157.4 million in the prior quarter.
  • Over five years, Finished Goods peaked at $170.3 million in Q4 2016 and troughed at $133.5 million in Q4 2018.
  • A 5-year average of $153.7 million and a median of $157.4 million in 2017 define the central range for Finished Goods.
  • Biggest five-year swings in Finished Goods: soared 51.2% in 2014 and later dropped 15.18% in 2018.
  • Year by year, Finished Goods stood at $164.2 million in 2014, then decreased by 12.91% to $143.0 million in 2015, then rose by 19.09% to $170.3 million in 2016, then fell by 7.57% to $157.4 million in 2017, then fell by 15.18% to $133.5 million in 2018.
  • Business Quant data shows Finished Goods for BIIB at $133.5 million in Q4 2018, $157.4 million in Q4 2017, and $170.3 million in Q4 2016.